Angiogenesis in Women With Angina Pectoris Who Are Not Candidates for Revascularization
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Robert Engler, MD
Cardium Therapeutics
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
47 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Alabama
Birmingham, Alabama, United States
- Banner Heart Hospital
Phoenix, Arizona, United States
- Southwest Heart
Tucson, Arizona, United States
- Access Clinical Trials
Beverly Hills, California, United States
- Cedars-Sinai Medical Center
Los Angeles, California, United States
- Mission Internal Medical Group
Mission Viejo, California, United States
- Ucsd Medical Center
San Diego, California, United States
- Aurora Denver Cardiology
Aurora, Colorado, United States
- South Denver Cardiology
Littleton, Colorado, United States
- Cardiovascular Research Institute
Washington D.C., District of Columbia, United States
- University of Florida
Gainesville, Florida, United States
- Florida Hospital
Orlando, Florida, United States
- St Joseph'S Research Institute
Atlanta, Georgia, United States
- St. Luke'S Idaho Cardiology Associates
Boise, Idaho, United States
- Fox Valley Cardiovascular Consultants
Aurora, Illinois, United States
- Midwest Heart Foundation
Lombard, Illinois, United States
- Northern Indiana Research Alliance
Fort Wayne, Indiana, United States
- the Care Group
Indianapolis, Indiana, United States
- Cardiovascular Associates
Louisville, Kentucky, United States
- Maine Medical Center
Portland, Maine, United States
- Massachusetts General Hospital
Boston, Massachusetts, United States
- University of Michigan Medical Center
Ann Arbor, Michigan, United States
- William Beaumont Hospital
Royal Oak, Michigan, United States
- St. Mary'S Duluth Clinic
Duluth, Minnesota, United States
- Minneapolis Heart Institute
Minneapolis, Minnesota, United States
- Mid America Heart Institute
Kansas City, Missouri, United States
- St. Anthony'S Medical Center
St Louis, Missouri, United States
- Bryanlgh Heart Institute
Lincoln, Nebraska, United States
- Creighton University
Omaha, Nebraska, United States
- the Valley Hospital
Ridgewood, New Jersey, United States
- Lenox Hill Heart & Vascular Institute
New York, New York, United States
- Duke University Medical Center
Durham, North Carolina, United States
- the Lindner Clinical Trial Center
Cincinnati, Ohio, United States
- North Ohio Heart Center
Elyria, Ohio, United States
- Oklahoma Cardiovascular Associates
Oklahoma City, Oklahoma, United States
- Providence Heart & Vascular Institute
Portland, Oregon, United States
- Heritage Cardiology Associates
Camp Hill, Pennsylvania, United States
- Geisinger Clinic
Danville, Pennsylvania, United States
- the Miriam Hospital
Providence, Rhode Island, United States
- the Stern Cardiovascular Center
Germantown, Tennessee, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 May 2007
- Primary completion
- 30 Nov 2009
- Completion
- —
- Last update posted
- 13 Feb 2013
- Registered enrollment
- 300
- Registry id
- NCT00438867
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.